Wiener Privatklinik
Non-Hodgkin's lymphoma treatment cost in Austria typically runs from $2,500 to $5,500 for chemotherapy, while advanced interventions like bone marrow transplantation can range between $50,000 and $270,000. Total expenses depend on the disease stage, treatment protocols, and clinic type. Patients often find competitive pricing in Austria compared to the US. Most specialized hematology-oncology care is centered in Vienna.
Typical Non-Hodgkin's Lymphoma Treatment Costs in Austria
Bookimed Expert Insight: For complex lymphoma cases, seeking professors affiliated with the Medical University of Vienna ensures high-level expertise. Univ.-Prof. Dr. Wolfgang Köstler at Wiener Privatklinik focuses on personalized cancer medicine and targeted therapies. Patients requiring long-term management benefit from Confraternitaet Private Hospital, where Prof. Johannes Drach directs specialized malignant lymphoma programs. These private institutions offer JCI-accredited environments and multilingual support for international patients seeking premium care.
| Turcja | Austria | Hiszpania | |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
| Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego | od $65,000 | od $150,000 | od $13,942 |
| Przeszczep szpiku kostnego | od $36,000 | od $140,000 | od $71,782 |
| Chemioterapia w raku piersi | od $1,200 | od $15,000 | od $3,500 |
| Chemioterapia | od $2,430 | od $2,500 | od $2,500 |
Państwo nie płacą za usługi Bookimed. Ceny leczenia chłoniaka nieziarniczego odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w leczeniu chłoniaka nieziarniczego. Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas leczenia chłoniaka nieziarniczego.
Prof. dr univ. Wolfgang Köstler jest wiodącym ekspertem w dziedzinie spersonalizowanej medycyny onkologicznej, specjalizującym się w leczeniu raka piersi oraz nowotworów ginekologicznych.
Profesor Drach kieruje programem leczenia szpiczaka mnogiego i chłoniaków złośliwych w Szpitalu Uniwersyteckim w Wiedniu — jednej z największych placówek w Europie. Łączy on doświadczenie kliniczne z pracą naukową.
Austria hosts top hematology centers offering advanced therapies for Non-Hodgkin lymphoma. Vienna General Hospital (AKH Wien) provides CAR T-cell therapy and complex bone marrow transplants. Wiener Privatklinik and Confraternität & Goldenes Kreuz are premier private options. These facilities combine specialized hematopathology with personalized immunotherapy and targeted biological treatments.
Bookimed Expert Insight: Patient data highlights that Wiener Privatklinik offers a compact, efficient environment. Its International Oncology Center includes 400 physicians and 30 specialized departments. This ensures rapid coordination between hematopathology and oncologists. Such speed is crucial for starting time-sensitive lymphoma treatments like immunotherapy. Unlike large public hospitals, private clinics often provide faster diagnostic turnaround for complex subtyping.
Patient Consensus: Patients value how centers coordinate biopsy, staging, and treatment starts without long delays. Those choosing private care in Vienna appreciate the direct communication during online consultations with oncologists.
Austria provides advanced modalities for Non-Hodgkin lymphoma including CAR T-cell therapy and targeted immunotherapy. Specialized centers offer allogeneic and autologous bone marrow transplantation for complex cases. Precision radiation and monoclonal antibody therapies are standard. These treatments are delivered by board-certified hematologists at JCI or ISO-accredited facilities.
Bookimed Expert Insight: Many leading specialists at Wiener Privatklinik also hold professorships at the Medical University of Vienna. This dual role creates a bridge between private personalized care and the latest clinical research. Dr. Wolfgang Köstler and Professor Johannes Drach represent this high level of academic expertise. They often participate in early clinical trials for individualized systemic therapies.
Patient Consensus: Patients emphasize the value of online consultations for reviewing complex histology results before traveling. Many recommend requesting a second pathology review to ensure the lymphoma subtype is accurately identified for targeted treatment.
Austrian hemato-oncologists determine non-Hodgkin lymphoma protocols by matching patient metrics with Onkopedia guidelines. These standards are developed by the Austrian, German, and Swiss hematology societies. Specialists use precise histological subtyping and PET-CT staging to choose between observation, immunotherapy, or intensive chemotherapy.
Bookimed Expert Insight: Protocol accuracy in Austria often relies on the deep academic ties of its physicians. Many specialists at Wiener Privatklinik also serve as professors at the Medical University of Vienna. This ensures patients receive protocols based on the latest biomarker developments and translational cancer research.
Patient Consensus: Patients note that treatment does not always start immediately. Many are surprised to learn that observation is often the safest path for certain slow-growing lymphoma subtypes.
Patients undergoing Non-Hodgkin lymphoma treatment in Austria can expect short-term fatigue, nausea, and mouth sores. Long-term effects may include peripheral neuropathy or persistent mental fog. Leading centers like Wiener Privatklinik offer specialized oncology care to manage these reactions and support overall recovery.
Bookimed Expert Insight: Lymphoma specialists in Vienna, such as Professor Dr. Johannes Drach, often emphasize pre-treatment nutrition and lifestyle assessments. Data from Wiener Privatklinik shows that involving over 400 specialists, many from the Medical University of Vienna, allows for highly personalized systemic therapies. This collaborative approach helps identify patients at higher risk for specific toxicities before the first infusion begins.
Patient Consensus: Patients note that extreme fatigue often peaks several days after treatment rather than immediately. Many emphasize that proactive oral care is essential to prevent painful mouth sores before they start.
International patients can enroll in Non-Hodgkin lymphoma clinical trials in Austria. Acceptance is determined by specific protocol rules and ethical committee approvals. Medical eligibility requires meeting precise genetic and staging criteria. Patients must often provide translated pathology reports and recent molecular testing results for review.
Bookimed Expert Insight: Clinical trial access in Vienna is often tied to academic affiliations. Specialists like Dr. Wolfgang Köstler and Dr. Johannes Drach are both professors at the Medical University of Vienna. This connection is vital because university-linked private clinics like Wiener Privatklinik often facilitate advanced systemic therapies. Choosing a doctor with deep ties to the Medical University can streamline the clinical review of your medical records.